Truist Securities Reiterates Buy Rating on Kymera Therapeutics (KYMR)
Go back to Truist Securities Reiterates Buy Rating on Kymera Therapeutics (KYMR)| (NASDAQ: KYMR) | Delayed: 111.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $111.95 | 52 Week High | $ | |||
| Open | $111.95 | 52 Week Low | $ | |||
| Day High | $111.95 | P/E | N/A | |||
| Day Low | $111.95 | EPS | $ | |||
| Volume | 132 | |||||
